- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 49.78M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 48.23M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 19.97M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.74M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.9M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $284.63K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.53M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $72.11M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $139.42M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $20.56M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $34M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $44.27M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $63.37M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $56.92M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $75.22M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $128.41M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $214.02M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $129.03M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $214.63M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.43 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.86 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.43 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.86 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $245.6K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $275.63K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $80.44K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $209.25K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$69.16M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$17.27M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.01M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $120.28K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.13M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $1.57M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.15M |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.69M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.7K |